Clinical Trial Update: Venetoclax and Obinutuzumab Followed by Epcoritamab for the Treatment of Untreated Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma, LonGEVity Trial [Phase 2]

View source ↗

Summary

Phase 2 LonGEVity trial evaluating a sequence of venetoclax and obinutuzumab followed by epcoritamab for untreated chronic lymphocytic leukemia and small lympho…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Small Lymphocytic Lymphoma

Drugs mentioned

• Epcoritamab (epcoritamab)
• Gazyva (Obinutuzumab)
• Venclyxto (Venetoclax)

Snippet

Sponsor: City of Hope Medical Center | Conditions: Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma | Phase 2 | Status: RECRUITING